This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Clinical Genomics Pty. Ltd., Commonwealth Scientific and Industrial Research Organisation. Active years: 2019.
Company Filing History:
1 out of 10 
1 out of 1,355 
Years Active: 2019
Title: Lloyd Douglas Graham - Innovator in Colorectal Neoplasm Diagnosis
Introduction
Lloyd Douglas Graham is an inventor based in New South Wales, Australia. He has made significant contributions to the field of medical diagnostics, particularly in the area of colorectal neoplasms. His innovative approach focuses on the use of nucleic acid molecules to identify the onset and progression of large intestine neoplasms.
Latest Patent Applications
Lloyd Douglas Graham's notable patent application is titled "METHOD OF DIAGNOSING NEOPLASMS." This invention relates to a nucleic acid molecule whose RNA and protein expression profiles indicate the onset, predisposition, and progression of large intestine neoplasms. Specifically, it targets colorectal neoplasms, such as adenomas and adenocarcinomas. The expression profiles outlined in this application are valuable for diagnosing and monitoring colorectal neoplasms. The method involves screening subjects for changes in the expression profile of the nucleic acid molecule markers.
Conclusion
Lloyd Douglas Graham's work represents a significant advancement in the diagnosis of colorectal neoplasms. His innovative methods have the potential to improve early detection and monitoring of these conditions, ultimately contributing to better patient outcomes.